{"id":116884,"date":"2021-04-02T15:06:55","date_gmt":"2021-04-02T07:06:55","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=116884"},"modified":"2021-04-02T15:06:57","modified_gmt":"2021-04-02T07:06:57","slug":"covid-19-china-vaccine-maker-sinovac-says-doubles-production-capacity","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=116884","title":{"rendered":"Covid-19: China vaccine maker Sinovac says doubles production capacity"},"content":{"rendered":"\n<figure class=\"wp-block-image\"><a href=\"http:\/\/www.bssnews.net\/wp-content\/uploads\/2021\/04\/Sinovac-says-doubles-production-capacity.jpg\"><img src=\"http:\/\/www.bssnews.net\/wp-content\/uploads\/2021\/04\/Sinovac-says-doubles-production-capacity.jpg\" alt=\"\"\/><\/a><\/figure>\n\n\n\n<p>BEIJING, April 2 (NNN-AGENCIES) &#8212; Chinese biopharmaceutical firm Sinovac said a third production line for its Covid-19 vaccine has been put<br>into use, doubling its annual capacity of the jabs to two billion doses.<\/p>\n\n\n\n<p>Its CoronaVac is one of four domestic vaccines given conditional approval<br>by Chinese authorities, which helps rush emergency drugs to market.<\/p>\n\n\n\n<p>On Wednesday, experts from the World Health Organization said an interim<br>analysis of clinical trial data from two Chinese vaccines, including<br>Sinovac\u2019s product, showed they demonstrated \u201csafety and good efficacy\u201d,<br>although more data is still needed.<\/p>\n\n\n\n<p>\u201cOver 200 million doses of CoronaVac have been delivered to over 20<br>countries, including China,\u201d said Sinovac in its latest statement.<\/p>\n\n\n\n<p>Although Sinovac\u2019s jab has been approved by domestic regulators, it has yet<br>to receive authorisation by what the WHO considers \u201ca stringent regulatory<br>authority\u201d, noted the UN health agency\u2019s Strategic Advisory Group of Experts on Immunization (SAGE).<\/p>\n\n\n\n<p>Sinovac is among Chinese firms to have submitted data in applications for<br>the WHO\u2019s emergency use listing, which opens the door for the jabs to join<br>the global Covax programme, which aims to ensure equitable access to Covid-19 vaccinations. &#8212; NNN-AGENCIES<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BEIJING, April 2 (NNN-AGENCIES) &#8212; Chinese biopharmaceutical firm Sinovac said a third production line for its Covid-19 vaccine has been putinto use, doubling its annual capacity of the jabs to two billion doses. Its CoronaVac is one of four domestic vaccines given conditional approvalby Chinese authorities, which helps rush emergency drugs to market. On Wednesday, [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":116885,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[215],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/116884"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=116884"}],"version-history":[{"count":0,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/116884\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/media\/116885"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=116884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=116884"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=116884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}